Pancuronium bromide enhances atrioventricular conduction in halothane-anesthetized dogs

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Anesthesiology

Background:

• Atrioventricular (AV) conduction is critical for cardiac rhythm regulation.
• Neuromuscular blocking agents can influence cardiac electrophysiology.
• Understanding pancuronium bromide's effects on AV conduction is important for patient safety.

Purpose of the Study:

• To investigate the electrophysiological effects of pancuronium bromide on atrioventricular conduction.
• To determine if pancuronium bromide influences the development or resolution of atrioventricular block.

Main Methods:

• His-bundle electrocardiography was performed in halothane-anesthetized dogs.
• Atrial pacing was conducted at various heart rates.
• The effect of a 0.1 mg/kg dose of pancuronium bromide on the A-H interval and AV block was assessed.

Main Results:

• Pancuronium bromide uniformly enhanced atrioventricular conduction, indicated by a decreased A-H interval.
• Wenckebach second-degree atrioventricular block, observed in 5 of 14 animals, was abolished by pancuronium bromide.
• The drug's effect on AV conduction was consistent across different heart rates.

Conclusions:

• Pancuronium bromide demonstrates a consistent enhancement of atrioventricular conduction.
• The abolition of Wenckebach block suggests a protective effect against certain types of AV block.
• Enhanced AV conduction may predispose certain patients to tachyarrhythmias, especially those with pre-existing atrial arrhythmias.